Negative crosstalk between M1 and M2 muscarinic autoreceptors involves endogenous adenosine activating A1 receptors at the rat motor endplate

Neuroscience Letters

Volumn 459, Issue 3, 2009, Pages 127-131

  Oliveira, Laura ^a   Timóteo, Maria Alexandrina ^a   Correia de Sá, Paulo ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

A1 adenosine receptors; ACh release; M1 muscarinic receptors; M2 muscarinic receptors; Neuromuscular junction

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ACETYLCHOLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE DEAMINASE; AUTORECEPTOR; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; NITROBENZYLTHIOINOSINE; OXOTREMORINE; PHENYLISOPROPYLADENOSINE; PIRENZEPINE; TRIMETHYLAMMONIUM SALT DERIVATIVE; TRITIUM; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 4-NITROBENZYLTHIOINOSINE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; ADENOSINE TRANSPORTER; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DRUG DERIVATIVE; MERCAPTOPURINE RIBOSIDE; N (1 METHYL 2 PHENYLETHYL)ADENOSINE; N-(1-METHYL-2-PHENYLETHYL)ADENOSINE; NUCLEOSIDE TRANSPORTER; XANTHINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; ELECTROSTIMULATION; FEMALE; HEMIDIAPHRAGM; INHIBITION KINETICS; MALE; NEGATIVE FEEDBACK; NERVE ENDING; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; WISTAR RAT;

(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE; ACETYLCHOLINE; ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; FEMALE; MALE; MOTOR ENDPLATE; NEUROTRANSMITTER AGENTS; NUCLEOSIDE TRANSPORT PROTEINS; OXOTREMORINE; PHRENIC NERVE; PIRENZEPINE; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; THIOINOSINE; TRITIUM; XANTHINES;

EID: 66049134517     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.05.001     Document Type: Article

References (33)

1. 1 receptors. Br. J. Pharmacol. 151 (2007) 541-550
2. Caulfield M.P., and Birdsall N.J.M. International union of pharmacology. XVII classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50 (1998) 279-290
3. Coe I., Zhang Y., McKenzie T., and Naydenova Z. PKC regulation of the human equilibrative nucleoside transporter, hENT1. FEBS Lett. 517 (2002) 201-205
4. Correia-de-Sá P., Adães S., Timóteo M.A., Vieira C., Magalhães-Cardoso T., Nascimento C., and Duarte-Araújo M. Fine-tuning modulation of myenteric motoneurons by endogenous adenosine: on the role of secreted adenosine deaminase. Auton Neurosci. 30 (2006) 211-224
5. 2A-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase. Naunyn Schmiedeberg's Arch. Pharmacol. 350 (1994) 514-522
6. 2A adenosine receptor facilitation of neuromuscular transmission: influence of stimulus paradigm on calcium mobilization. J. Neurochem. 74 (2000) 2462-2469
7. 3H]acetylcholine release from the rat motor-nerve endings. Eur. J. Pharmacol. 406 (2000) 355-362
8. 2A facilitatory adenosine receptors activation balance depends on motor nerve stimulation paradigms at the rat hemidiaphragm. J. Neurophysiol. 76 (1996) 3910-3919
9. Cruz L.J., Gray W.R., Olivera B.M., Zeikus R.D., Kerr L., Yoshikami D., and Moczydlowski E. Conus geographus toxins that discriminates between neuronal and muscle sodium channels. J. Biol. Chem. 260 (1985) 9280-9288
10. Cunha R.A., Correia-de-Sá P., Sebastião A.M., and Ribeiro J.A. Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br. J. Pharmacol. 119 (1996) 253-260
11. Cunha R.A., and Ribeiro J.A. ATP as a presynaptic modulator. Life Sci. 68 (2000) 119-137
12. Faria M., Oliveira L., Timóteo M.A., Lobo M.G., and Correia-de-Sá P. Blockade of neuronal facilitatory nicotinic receptors containing α3β2 subunits contribute to tetanic fade in the rat isolated diaphragm. Synapse 49 (2003) 77-88
13. Griffith D.A., and Jarvis S.M. Nucleoside and nucleobase transport systems of mammalian cells. Biochim. Biophys. Acta 1286 (1996) 153-181
14. Hamilton B.R., and Smith D.O. Autoreceptor-mediated purinergic and cholinergic inhibition of motor nerve terminal calcium currents in rat. J. Physiol. (London) 432 (1991) 327-341
15. Hirsh J.K., and Silinsky E.M. Inhibition of spontaneous acetylcholine secretion by 2-chloroadenosine as revealed by a protein kinase inhibitor at the mouse neuromuscular junction. Br. J. Pharmacol. 135 (2002) 1897-1902
16. Lanzafame A.A., Christopoulos A., and Mitchelson F. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Receptors Channels 9 (2003) 241-260
17. Lippe C., and Ardizzone C. Actions of vasopressine and isoprenaline on the ionic transport across the isolated frog skin in the presence and the absence of adenyl cyclase inhibitors MDL 12,330 and SQ22536. Comp. Biochem. Physiol. 99 (1991) 209-211
18. Lohse M.J., Maurer K., Gensheimer H.P., and Schwabe U. Dual actions of adenosine on rat peritoneal mast cells. Naunyn Schmiedeberg's Arch. Pharmacol. 335 (1987) 555-560
19. 2A receptor facilitation of acetylcholine release at rat motor nerve terminals. J. Physiol. (London) 549 (2003) 399-408
20. Obata T., Kubora S., and Yamanaka Y. Histamine increases interstitial adenosine concentration via activation of ecto-5′-nucleotidase in rat hearts in vivo. J. Pharmacol. Exp. Ther. 298 (2001) 71-76
21. 2-receptors on rat motoneurons. Signal Transduction 6 (2006) 19-31
22. 1 receptors on rat motoneurons. NeuroSignals 14 (2005) 262-272
23. 3H]-acetylcholine release from the rat motor nerve terminals. Eur. J. Neurosci. 15 (2002) 1728-1736
24. Re L. Modulation of acetylcholine release by presynaptic muscarinic autoreceptors. Acta Physiol. Pharmacol. Ther. Latinoam. 49 (1999) 215-223
25. Roszek B., Baan G.C., and Huijing P.A. Decreasing stimulation frequency-dependent length-force characteristics of rat muscle. J. Appl. Physiol. 77 (1994) 2115-2124
26. Sebastião A.M., and Ribeiro J.A. Fine-tuning neuromodulation by adenosine. Trends Pharmacol. Sci. 21 (2000) 341-346
27. Shakirzyanova A.V., Bukharaeva E.A., Nikolsky E.E., and Giniatullin R.A. Negative crosstalk between presynaptic adenosine and acetylcholine receptors. Eur. J. Neurosci. 24 (2006) 105-115
28. Silinsky E.M. Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction. J. Physiol. (London) 558 (2004) 389-401
29. Silinsky E.M. On the association between transmitter secretion and release of adenine nucleotides from mammalian motor nerve terminals. J. Physiol. (London) 247 (1975) 145-162
30. 1 adenosine receptor activation. Biochem. Pharmacol. 59 (2000) 477-483
31. Vizi E.S., and Somogyi G.T. Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic) - and negative (muscarinic) - feedback modulation. Br. J. Pharmacol. 97 (1989) 65-70
32. Wessler I., Diener A., and Offermann M. Facilitatory and inhibitory muscarinic receptors on the rat phrenic nerve: effects of pirenzepine and dicyclomine. Naunyn-Schmiedeberg's Arch. Pharmacol. 338 (1988) 138-142
33. 3H]-acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn-Schmiedeberg's Arch. Pharmacol. 334 (1986) 357-364